# Bloom Energy Corp: financial statements, quarterly

BE · NYSE · CIK 1664703 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/be.md) · [Financials](/companies/be/financials.md) · [Filings](/companies/be/filings.md) · [Insiders](/companies/be/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/be/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [341 d](/filings/0001628280-26-006516.md) | [226](/filings/0001628280-25-021160.md) | [326](/filings/0001628280-25-037074.md) | [322](/filings/0001628280-25-046844.md) | [567 d](/filings/0001628280-26-006516.md) | [319](/filings/0001628280-26-028021.md) | [396](/filings/0001628280-26-050325.md) | [513](/filings/0001628280-26-066931.md) | [773 d](/filings/0001628280-26-006516.md) | [746](/filings/0001628280-26-028021.md) | [1,061](/filings/0001628280-26-050325.md) | [1,231](/filings/0001628280-26-066931.md) |
| Cost of revenue | $m | [265 d](/filings/0001628280-26-006516.md) | [197](/filings/0001628280-25-021160.md) | [267](/filings/0001628280-25-037074.md) | [252](/filings/0001628280-25-046844.md) | [353 d](/filings/0001628280-26-006516.md) | [237](/filings/0001628280-26-028021.md) | [294](/filings/0001628280-26-050325.md) | [367](/filings/0001628280-26-066931.md) | [538 d](/filings/0001628280-26-006516.md) | [526](/filings/0001628280-26-028021.md) | [710](/filings/0001628280-26-050325.md) | [819](/filings/0001628280-26-066931.md) |
| Gross profit | $m | [92.4 d](/filings/0001628280-26-006516.md) | [38.1](/filings/0001628280-25-021160.md) | [68.5](/filings/0001628280-25-037074.md) | [78.7](/filings/0001628280-25-046844.md) | [219 d](/filings/0001628280-26-006516.md) | [88.7](/filings/0001628280-26-028021.md) | [107](/filings/0001628280-26-050325.md) | [152](/filings/0001628280-26-066931.md) | [240 d](/filings/0001628280-26-006516.md) | [226](/filings/0001628280-26-028021.md) | [356](/filings/0001628280-26-050325.md) | [417](/filings/0001628280-26-066931.md) |
| Research and development | $m | [33.6 d](/filings/0001628280-26-006516.md) | [35.5](/filings/0001628280-25-021160.md) | [37.4](/filings/0001628280-25-037074.md) | [36.3](/filings/0001628280-25-046844.md) | [39.5 d](/filings/0001628280-26-006516.md) | [40.6](/filings/0001628280-26-028021.md) | [40.8](/filings/0001628280-26-050325.md) | [48.7](/filings/0001628280-26-066931.md) | [55.9 d](/filings/0001628280-26-006516.md) | [56.8](/filings/0001628280-26-028021.md) | [58.9](/filings/0001628280-26-050325.md) | [64.1](/filings/0001628280-26-066931.md) |
| Operating income | $m | [12.9 d](/filings/0001628280-26-006516.md) | [(49.0)](/filings/0001628280-25-021160.md) | [(23.1)](/filings/0001628280-25-037074.md) | [(9.7)](/filings/0001628280-25-046844.md) | [105 d](/filings/0001628280-26-006516.md) | [(19.1)](/filings/0001628280-26-028021.md) | [(3.5)](/filings/0001628280-26-050325.md) | [7.8](/filings/0001628280-26-066931.md) | [87.5 d](/filings/0001628280-26-006516.md) | [72.2](/filings/0001628280-26-028021.md) | [182](/filings/0001628280-26-050325.md) | [225](/filings/0001628280-26-066931.md) |
| Interest expense | $m | [14.6 d](/filings/0001628280-25-008747.md) | [14.5](/filings/0001628280-25-021160.md) | [15.4](/filings/0001628280-25-037074.md) | [16.8](/filings/0001628280-25-046844.md) | [15.9 d](/filings/0001628280-25-008747.md) | [14.4](/filings/0001628280-26-028021.md) | [14.4](/filings/0001628280-26-050325.md) | [14.4](/filings/0001628280-26-066931.md) | [10.6 d](/filings/0001628280-26-006516.md) | [8.6](/filings/0001628280-26-028021.md) | [8.9](/filings/0001628280-26-050325.md) | [7.5](/filings/0001628280-26-066931.md) |
| Income tax | $m | [0.8 d](/filings/0001628280-26-006516.md) | [(0.5)](/filings/0001628280-25-021160.md) | [0.9](/filings/0001628280-25-037074.md) | [0.1](/filings/0001628280-25-046844.md) | [0.4 d](/filings/0001628280-26-006516.md) | [0.4](/filings/0001628280-26-028021.md) | [1.0](/filings/0001628280-26-050325.md) | [0.3](/filings/0001628280-26-066931.md) | [1.0 d](/filings/0001628280-26-006516.md) | [0.4](/filings/0001628280-26-028021.md) | [1.5](/filings/0001628280-26-050325.md) | [0.8](/filings/0001628280-26-066931.md) |
| Net income | $m | [9.9 d](/filings/0001628280-24-005035.md) | [(56.5)](/filings/0001628280-25-021160.md) | [(61.2)](/filings/0001628280-25-037074.md) | [(14.6)](/filings/0001628280-25-046844.md) | [105 d](/filings/0001628280-26-006516.md) | [(23.4)](/filings/0001628280-26-028021.md) | [(42.2)](/filings/0001628280-26-050325.md) | [(23.0)](/filings/0001628280-26-066931.md) | [1.4 d](/filings/0001628280-26-006516.md) | [73.7](/filings/0001628280-26-028021.md) | [199](/filings/0001628280-26-050325.md) | [249](/filings/0001628280-26-066931.md) |
| Diluted EPS | $ per share | not reported | [(0.25)](/filings/0001628280-25-021160.md) | [(0.27)](/filings/0001628280-25-037074.md) | [(60.00)](/filings/0001628280-25-046844.md) | not reported | [(0.10)](/filings/0001628280-26-028021.md) | [(0.18)](/filings/0001628280-26-050325.md) | [(0.10)](/filings/0001628280-26-066931.md) | not reported | [0.23](/filings/0001628280-26-028021.md) | [0.62](/filings/0001628280-26-050325.md) | [0.78](/filings/0001628280-26-066931.md) |
| Basic EPS | $ per share | not reported | [(0.25)](/filings/0001628280-25-021160.md) | [(0.27)](/filings/0001628280-25-037074.md) | [(60.00)](/filings/0001628280-25-046844.md) | not reported | [(0.10)](/filings/0001628280-26-028021.md) | [(0.18)](/filings/0001628280-26-050325.md) | [(0.10)](/filings/0001628280-26-066931.md) | not reported | [0.25](/filings/0001628280-26-028021.md) | [0.68](/filings/0001628280-26-050325.md) | [0.85](/filings/0001628280-26-066931.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [665](/filings/0001628280-25-008747.md) | [516](/filings/0001628280-24-022309.md) | [582](/filings/0001628280-24-036219.md) | [496](/filings/0001628280-24-046411.md) | [803](/filings/0001628280-26-006516.md) | [795](/filings/0001628280-25-021160.md) | [575](/filings/0001628280-25-037074.md) | [595](/filings/0001628280-25-046844.md) | [2,454](/filings/0001628280-26-066931.md) | [2,491](/filings/0001628280-26-028021.md) | [2,667](/filings/0001628280-26-050325.md) | [2,487](/filings/0001628280-26-066931.md) |
| Current assets | $m | [1,693](/filings/0001628280-25-008747.md) | [1,580](/filings/0001628280-24-022309.md) | [1,830](/filings/0001628280-24-036219.md) | [1,903](/filings/0001628280-24-046411.md) | [2,044](/filings/0001628280-26-006516.md) | [2,009](/filings/0001628280-25-021160.md) | [1,933](/filings/0001628280-25-037074.md) | [2,048](/filings/0001628280-25-046844.md) | [3,731](/filings/0001628280-26-066931.md) | [3,955](/filings/0001628280-26-028021.md) | [4,590](/filings/0001628280-26-050325.md) | [5,208](/filings/0001628280-26-066931.md) |
| Total assets | $m | [2,414](/filings/0001628280-25-008747.md) | [2,286](/filings/0001628280-24-022309.md) | [2,548](/filings/0001628280-24-036219.md) | [2,605](/filings/0001628280-24-046411.md) | [2,657](/filings/0001628280-26-006516.md) | [2,608](/filings/0001628280-25-021160.md) | [2,530](/filings/0001628280-25-037074.md) | [2,638](/filings/0001628280-25-046844.md) | [4,397](/filings/0001628280-26-066931.md) | [4,665](/filings/0001628280-26-028021.md) | [5,628](/filings/0001628280-26-050325.md) | [6,572](/filings/0001628280-26-066931.md) |
| Current liabilities | $m | [470](/filings/0001628280-25-008747.md) | [355](/filings/0001628280-24-022309.md) | [393](/filings/0001628280-24-036219.md) | [567](/filings/0001628280-24-046411.md) | [637](/filings/0001628280-26-006516.md) | [584](/filings/0001628280-25-021160.md) | [387](/filings/0001628280-25-037074.md) | [466](/filings/0001628280-25-046844.md) | [624](/filings/0001628280-26-066931.md) | [787](/filings/0001628280-26-028021.md) | [1,123](/filings/0001628280-26-050325.md) | [1,392](/filings/0001628280-26-066931.md) |
| Total liabilities | $m | [1,893](/filings/0001628280-25-008747.md) | [1,797](/filings/0001628280-24-022309.md) | [2,101](/filings/0001628280-24-036219.md) | [2,150](/filings/0001628280-24-046411.md) | [2,072](/filings/0001628280-26-006516.md) | [2,007](/filings/0001628280-25-021160.md) | [1,911](/filings/0001628280-25-037074.md) | [1,961](/filings/0001628280-25-046844.md) | [3,604](/filings/0001628280-26-066931.md) | [3,717](/filings/0001628280-26-028021.md) | [3,988](/filings/0001628280-26-050325.md) | [4,608](/filings/0001628280-26-066931.md) |
| Long-term debt | $m | [847](/filings/0001628280-25-008747.md) | [848](/filings/0001628280-24-022309.md) | [1,125](/filings/0001628280-24-036219.md) | [1,013](/filings/0001628280-24-046411.md) | [1,014](/filings/0001628280-26-006516.md) | [1,016](/filings/0001628280-25-021160.md) | [1,129](/filings/0001628280-25-037074.md) | [1,131](/filings/0001628280-25-046844.md) | [2,614](/filings/0001628280-26-066931.md) | [2,599](/filings/0001628280-26-028021.md) | [2,471](/filings/0001628280-26-050325.md) | [2,473](/filings/0001628280-26-066931.md) |
| Current portion of debt | $m | [0.0](/filings/0001628280-25-008747.md) | [0.0](/filings/0001628280-24-022309.md) | [0.0](/filings/0001628280-24-036219.md) | [114](/filings/0001628280-24-046411.md) | [114](/filings/0001628280-26-006516.md) | [115](/filings/0001628280-25-021160.md) | [3.7](/filings/0001628280-25-037074.md) | [1.4](/filings/0001628280-25-046844.md) | [4.2](/filings/0001628280-26-066931.md) | [4.0](/filings/0001628280-26-028021.md) | [7.3](/filings/0001628280-26-050325.md) | [3.0](/filings/0001628280-26-066931.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | [114](/filings/0001628280-24-046411.md) | [114](/filings/0001628280-26-006516.md) | [115](/filings/0001628280-25-021160.md) | [3.7](/filings/0001628280-25-037074.md) | [1.4](/filings/0001628280-25-046844.md) | [4.2](/filings/0001628280-26-066931.md) | [4.0](/filings/0001628280-26-028021.md) | [7.3](/filings/0001628280-26-050325.md) | [3.0](/filings/0001628280-26-066931.md) |
| Shareholders' equity | $m | [502](/filings/0001628280-25-008747.md) | [466](/filings/0001628280-24-022309.md) | [423](/filings/0001628280-24-036219.md) | [431](/filings/0001628280-24-046411.md) | [562](/filings/0001628280-26-006516.md) | [578](/filings/0001628280-25-021160.md) | [595](/filings/0001628280-25-037074.md) | [653](/filings/0001628280-25-046844.md) | [769](/filings/0001628280-26-066931.md) | [921](/filings/0001628280-26-028021.md) | [1,612](/filings/0001628280-26-050325.md) | [1,933](/filings/0001628280-26-066931.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [122 d](/filings/0001628280-26-006516.md) | [(147)](/filings/0001628280-25-021160.md) | [(175) d](/filings/0001628280-25-037074.md) | [(69.5) d](/filings/0001628280-25-046844.md) | [484 d](/filings/0001628280-26-006516.md) | [(111)](/filings/0001628280-26-028021.md) | [(213) d](/filings/0001628280-26-050325.md) | [19.7 d](/filings/0001628280-26-066931.md) | [418 d](/filings/0001628280-26-006516.md) | [73.6](/filings/0001628280-26-028021.md) | [226 d](/filings/0001628280-26-050325.md) | [(27.1) d](/filings/0001628280-26-066931.md) |
| Capital expenditure | $m | [16.3 d](/filings/0001628280-26-006516.md) | [21.4](/filings/0001628280-25-021160.md) | [12.0 d](/filings/0001628280-25-037074.md) | [14.3 d](/filings/0001628280-25-046844.md) | [11.1 d](/filings/0001628280-26-006516.md) | [14.3](/filings/0001628280-26-028021.md) | [7.2 d](/filings/0001628280-26-050325.md) | [12.3 d](/filings/0001628280-26-066931.md) | [23.0 d](/filings/0001628280-26-006516.md) | [26.2](/filings/0001628280-26-028021.md) | [51.6 d](/filings/0001628280-26-050325.md) | [153 d](/filings/0001628280-26-066931.md) |
| Dividends paid | $m | [0.0 d](/filings/0001628280-26-006516.md) | not reported | not reported | [0.0 d](/filings/0001628280-25-046844.md) | [0.0 d](/filings/0001628280-26-006516.md) | not reported | not reported | [0.0 d](/filings/0001628280-26-066931.md) | [0.0 d](/filings/0001628280-26-006516.md) | not reported | not reported | [0.0 d](/filings/0001628280-26-066931.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [207](/filings/0001628280-24-022309.md) | [209](/filings/0001628280-24-036219.md) | [211](/filings/0001628280-24-046411.md) | [226](/filings/0001628280-25-021160.md) | [227](/filings/0001628280-25-037074.md) | [228](/filings/0001628280-25-046844.md) | [230](/filings/0001628280-26-028021.md) | [233](/filings/0001628280-26-050325.md) | [235](/filings/0001628280-26-066931.md) | [320](/filings/0001628280-26-028021.md) | [323](/filings/0001628280-26-050325.md) | [324](/filings/0001628280-26-066931.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 295,656,689 at 2026-10-19, from the cover of the [10-Q filed 2026-10-22](/filings/0001628280-26-066931.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.